Filtered By:
Condition: Heart Failure
Procedure: Coronary Artery Bypass Graft
This page shows you your search results in order of relevance. This is page number 9.
Order by Relevance | Date
Total 322 results found since Jan 2013.
Effects of Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting on Clinical Outcomes in Patients with Reduced Ejection Fraction Heart Failure and Coronary Heart Disease: A Meta-Analysis
CONCLUSIONS: The mortality rates of PCI and CABG were similar in patients with CHD complicated with HFrEF. Compared with PCI, CABG had a lower incidence of MACE, MI, HF, and revascularization, and a higher incidence of stroke or TIA.PMID:36856505 | DOI:10.1532/hsf.5169
Source: The Heart Surgery Forum - March 1, 2023 Category: Cardiovascular & Thoracic Surgery Authors: Zi-Xiang Yu Ju Yan Ming-Yuan Wang Rong Chen Jun-Yi Luo Xiao-Mei Li Xiang Xie Yi-Tong Ma Source Type: research
GDF ‐15 at admission predicts cardiovascular death, heart failure, and bleeding outcomes in patients with CAD
ConclusionsIn patients with CAD, admission levels of GDF-15 were associated with an increased 1 year risk of CV death, HF, and bleeding outcomes, but not with thrombotic events. GDF-15 may be a prognostic biomarker for CV death, HF, and bleeding outcomes and could be used to refine the risk assessment of these specific clinical outcomes.Trial Registration:ClinicalTrials.gov Identifier: NCT04044066
Source: ESC Heart Failure - August 25, 2023 Category: Cardiology Authors: Jiali Wang,
Tao Zhang,
Feng Xu,
Wei Gao,
Ming Chen,
Huadong Zhu,
Jun Xu,
Xinxin Yin,
Jiaojiao Pang,
Song Zhang,
Mengke Wei,
Jiahao Chen,
Ying Liu,
Xuezhong Yu,
Derek P. Chew,
Yuguo Chen Tags: Original Article Source Type: research
Treatment of functional mitral valve regurgitation with the permanent percutaneous transvenous mitral annuloplasty system: Results of the multicenter international Percutaneous Transvenous Mitral Annuloplasty System to Reduce Mitral Valve Regurgitation in Patients with Heart Failure trial
Conclusions: Overall, PTMA had mild impact on MR reduction, left ventricular remodeling, QOL, and exercise capacity. During follow-up, the risk/benefit ratio remained suboptimal.
Source: American Heart Journal - February 18, 2013 Category: Cardiology Authors: Jimmy MacHaalany, Luc Bilodeau, Rainer Hoffmann, Stefan Sack, Horst Sievert, Josef Kautzner, Christoph Hehrlein, Patrick Serruys, Mario Sénéchal, Pamela Douglas, Olivier F. Bertrand Tags: Valvular and Congenital Heart Disease Source Type: research
